Zagreb, Croatia, 3rd March 2015 Fidelta, a Galapagos company, announced today the achievement of a milestone, thereby completing the first phase of an integrated drug discovery project that started in April 2014. Todays payment remains undisclosed. Furthermore, the next phase of the project has been agreed, which will contribute significantly to Fidelta's revenues in 2015.Phil Dudfield...